About
Specific Diagnostics is a medical diagnostics company based in Mountain View, California, founded in 2011. The company specializes in developing rapid microbiology diagnostic systems using patented metabolomics technology. This technology detects and characterizes infections by sensing volatile small molecule emissions from microorganisms during growth. The flagship product, the SPECIFIC REVEAL Rapid AST System, provides antimicrobial susceptibility testing results from positive blood cultures in about 5 hours, significantly faster than traditional methods. This system aids clinicians in selecting effective antibiotic therapies quickly, which is crucial in critical conditions like sepsis. Specific Diagnostics also collaborates with genomic research centers to enhance pathogen characterization and diagnostics. In 2022, Specific Diagnostics was acquired by bioMérieux, a leader in in vitro diagnostics, which has expanded its reach in the global market. The company targets clinical microbiology laboratories and healthcare providers, focusing on improving outcomes in infectious disease management, particularly for bloodstream infections and sepsis.
Technologies
Keywords
Company Information
-
Employees 34
-
Founded 2011
-
Annual Revenue $7000000
-
Total Funding $12500000
Location
Mountain View, California, United States
